Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng

Anti-apoptotic proteins such as BCL-2, BCL-XL and MCL-1 bind with pro-apoptotic proteins to induce apoptosis mechanism. BCL-2 family proteins are key regulators of apoptosis process. Over expression of these anti-apoptotic proteins lead to several cancers by preventing apoptosis. A number of studies revealed that ginseng derivatives reduce tumor growth. Ginseng, the most valuable medicinal herb found in eastern Asia belongs to Araliaceae family. In this study, docking simulations were performed for anti-apoptotic proteins with several ginsenosides from Panax ginseng. Our finding shows ginsenosides Rf, Rg1, Rg3 and Rh2 have more binding affinity with BCL-2, BCL-XL and MCL-1 and other ginsenosides also interact with each anti-apoptotic proteins. Therefore, ginseng derivatives represent a novel class of potent inhibitors and could be used for cancer chemotherapy.

[1]  C. Yuan,et al.  Ginseng pharmacology: multiple constituents and multiple actions. , 1999, Biochemical pharmacology.

[2]  J. Ponder,et al.  Force fields for protein simulations. , 2003, Advances in protein chemistry.

[3]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[4]  Y. Kim,et al.  Generation and gene ontology based analysis of expressed sequence tags (EST) from a Panax ginseng C. A. Meyer roots , 2010, Molecular Biology Reports.

[5]  K. Leung,et al.  Pharmacology of ginsenosides: a literature review , 2010, Chinese medicine.

[6]  Qing Zhang,et al.  The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema , 2004, Nucleic Acids Res..

[7]  M. Heinrich,et al.  Medicinal plants and phytomedicines , 2005 .

[8]  Shin-Jeong Lee,et al.  20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. , 2006, Biochemical and biophysical research communications.

[9]  Martin Raff,et al.  Cell suicide for beginners , 1998, Nature.

[10]  Gert Vriend,et al.  Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.

[11]  A. Keating,et al.  Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. , 2010, Journal of molecular biology.

[12]  S. Y. Choi,et al.  Non-organ specific cancer prevention of ginseng: a prospective study in Korea. , 1998, International journal of epidemiology.

[13]  A. Petros,et al.  Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.

[14]  A. Godzik,et al.  Characterization of the anti-apoptotic mechanism of Bcl-B. , 2003, The Biochemical journal.

[15]  I. Nagata,et al.  Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells , 1998, Japanese journal of cancer research : Gann.

[16]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[17]  Sangdun Choi,et al.  Structure-Function Relationship of Cytoplasmic and Nuclear IκB Proteins: An In Silico Analysis , 2010, PloS one.

[18]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[19]  D. P. Briskin.  Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. , 2000, Plant physiology.

[20]  I Lebedeva,et al.  Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. , 2000, Cancer research.

[21]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[22]  S. Ko,et al.  Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells , 2004, Archives of pharmacal research.

[23]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[24]  E. Ernst,et al.  The efficacy of ginseng. A systematic review of randomised clinical trials , 1999, European Journal of Clinical Pharmacology.

[25]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[26]  D. Rhee,et al.  Biological Activities and Chemistry of Saponins from Panax ginseng C. A. Meyer , 2005, Phytochemistry Reviews.

[27]  Mark Watson,et al.  Optimizing the use of open-source software applications in drug discovery. , 2006, Drug discovery today.

[28]  Shin Kim,et al.  Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL or Bax in C6Bu-1 cells , 1999, Archives of pharmacal research.

[29]  À. Sierra,et al.  Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state , 2002, International journal of cancer.

[30]  P. Arora,et al.  Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. , 2005, Angewandte Chemie.

[31]  C. Stubberfield,et al.  Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[32]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[33]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[34]  T. Kakizoe.  Asian studies of cancer chemoprevention: latest clinical results. , 2000, European journal of cancer.

[35]  Evan Bolton,et al.  An overview of the PubChem BioAssay resource , 2009, Nucleic Acids Res..

[36]  Erinna F. Lee,et al.  Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family , 2007, Cell Death and Differentiation.

[37]  Kwang-tae Choi,et al.  Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer , 2008, Acta Pharmacologica Sinica.

[38]  Richard M. Jackson,et al.  Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites , 2005, Bioinform..

[39]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[40]  T. Chittenden,et al.  A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. , 1995, The EMBO journal.